<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">343744</id>
  <title nil="true"/>
  <common-name>9-bromo-5-methyl-2-naphthalen-2-yl-5-pyridin-4-yl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine</common-name>
  <description>9-bromo-5-methyl-2-naphthalen-2-yl-5-pyridin-4-yl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is a chemical compound with the formula C26H20BrN3O. It has an average molecular weight of 470.40 g/mol.</description>
  <cas>303059-91-8</cas>
  <pubchem-id>5052883</pubchem-id>
  <chemical-formula>C26H20BrN3O</chemical-formula>
  <weight>470.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T05:17:34Z</created-at>
  <updated-at type="dateTime">2026-08-31T05:17:34Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1(N2C(CC(=N2)C3=CC4=CC=CC=C4C=C3)C5=C(O1)C=CC(=C5)Br)C6=CC=NC=C6</moldb-smiles>
  <moldb-formula>C26H20BrN3O</moldb-formula>
  <moldb-inchi>InChI=1S/C26H20BrN3O/c1-26(20-10-12-28-13-11-20)30-24(22-15-21(27)8-9-25(22)31-26)16-23(29-30)19-7-6-17-4-2-3-5-18(17)14-19/h2-15,24H,16H2,1H3</moldb-inchi>
  <moldb-inchikey>DZKBQHXPOBVWSY-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">469.07897</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM339637</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>9-bromo-5-methyl-2-naphthalen-2-yl-5-pyridin-4-yl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzoxazines</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0294118</sync-id>
  <structure-inchikey>DZKBQHXPOBVWSY-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2000000000000000000000000000000000000000000180000010000000000000000000000200000000000002100000000000000080000000000000000100000000008000000000200000000000000800000000000000000800100000200000000000000000000000000100000800400020100008000000001000000101110000048000001800000000000000004800000000101800000000000000020200000008000000008000000080000000000008000000200000000000000000000000000000000001000000100008000000000000000000000000200000000000000000000000001002040000000400000100800404000000000000000010000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAfAAAAJAAAAIABBgBgAAAAAQMGACAAAAAE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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:43:05Z</structure-indexed-at>
</compound>
